AU4973896A - Ink4c-p18 and ink4d-p19, inhibitors of cyclin-depedent kinases cdk4 and cdk6, and uses thereof - Google Patents

Ink4c-p18 and ink4d-p19, inhibitors of cyclin-depedent kinases cdk4 and cdk6, and uses thereof

Info

Publication number
AU4973896A
AU4973896A AU49738/96A AU4973896A AU4973896A AU 4973896 A AU4973896 A AU 4973896A AU 49738/96 A AU49738/96 A AU 49738/96A AU 4973896 A AU4973896 A AU 4973896A AU 4973896 A AU4973896 A AU 4973896A
Authority
AU
Australia
Prior art keywords
ink4d
ink4c
depedent
cdk6
cyclin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49738/96A
Inventor
James R Downing
Hiroshi Hirai
Tsukasa Okuda
Charles J Sherr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Jude Childrens Research Hospital
Original Assignee
St Jude Childrens Research Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23516066&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU4973896(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by St Jude Childrens Research Hospital filed Critical St Jude Childrens Research Hospital
Publication of AU4973896A publication Critical patent/AU4973896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU49738/96A 1995-02-06 1996-02-06 Ink4c-p18 and ink4d-p19, inhibitors of cyclin-depedent kinases cdk4 and cdk6, and uses thereof Abandoned AU4973896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/384,106 US6033847A (en) 1995-02-06 1995-02-06 InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
PCT/US1996/001643 WO1996024603A1 (en) 1995-02-06 1996-02-06 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF
US384106 1999-08-27

Publications (1)

Publication Number Publication Date
AU4973896A true AU4973896A (en) 1996-08-27

Family

ID=23516066

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49738/96A Abandoned AU4973896A (en) 1995-02-06 1996-02-06 Ink4c-p18 and ink4d-p19, inhibitors of cyclin-depedent kinases cdk4 and cdk6, and uses thereof

Country Status (6)

Country Link
US (1) US6033847A (en)
EP (1) EP0808321A1 (en)
JP (1) JPH10513359A (en)
AU (1) AU4973896A (en)
CA (1) CA2212376A1 (en)
WO (1) WO1996024603A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ284612A (en) * 1994-03-18 1997-09-22 Univ Utah Res Found Multiple tumour suppressor (mts) gene and its use in the diagnosis and treatment of cancer
US5981702A (en) * 1995-09-21 1999-11-09 Cold Spring Harbor Laboratory Cyclin/CDK associated proteins, and uses related thereto
WO1998037190A1 (en) * 1997-02-20 1998-08-27 Hepavec Aktiengesellschaft Für Gentherapie Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
US6187535B1 (en) 1998-02-18 2001-02-13 Institut Pasteur Fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides
DE19829473C2 (en) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Procedure for early diagnosis of carcinomas
US7306926B2 (en) * 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
AU7732900A (en) * 1999-09-30 2001-04-30 National Jewish Medical And Research Center Method for regulating cell growth and assays related thereto
US7306925B2 (en) * 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
EP1333278B1 (en) 2002-02-01 2004-03-10 MTM molecular tools in medicine Methods for monitoring and prognosis of disease course of gastrointestinal tumors
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
EP1365032B1 (en) * 2002-05-21 2008-11-19 MTM Laboratories AG Marker molecules associated with lung tumors
DE60200248T2 (en) * 2002-08-01 2005-01-27 Mtm Laboratories Ag Procedure for solution-based diagnosis
EP1422526A1 (en) * 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
DE60300339T2 (en) * 2003-08-25 2006-04-13 Mtm Laboratories Ag Method for the detection of carcinomas in solubilized cervical body samples
US7863044B2 (en) * 2003-10-24 2011-01-04 Tao Cheng p18 in stem cell manipulations
CN102140139B (en) * 2010-02-03 2013-01-09 吉林大学 Antitumor human single-chain antibody
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
KR20150092637A (en) 2014-02-05 2015-08-13 삼성전자주식회사 p16 protein variant and composition for preventing or treating a cancer containing the same
EP3172222A4 (en) 2014-07-24 2018-03-21 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
CN108348556A (en) * 2015-11-02 2018-07-31 欧瑞3恩公司 Cell-cycle arrest improves the efficiency for generating induced multi-potent stem cell
WO2018148595A1 (en) 2017-02-10 2018-08-16 Washington University Antibodies to tip1 and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5174986A (en) * 1989-07-05 1992-12-29 Genpharm International, Inc. Method for determining oncogenic potential of a chemical compound
EP0584264A1 (en) * 1991-05-16 1994-03-02 Cold Spring Harbor Laboratory D-type cyclin and uses related thereto
US5185260A (en) * 1991-08-29 1993-02-09 The United States Of America As Represented By The United States Department Of Energy Method for distinguishing normal and transformed cells using G1 kinase inhibitors
AU5549696A (en) * 1995-04-17 1996-11-07 Regents Of The University Of California, The P19: a cell cycle inhibitor

Also Published As

Publication number Publication date
EP0808321A1 (en) 1997-11-26
JPH10513359A (en) 1998-12-22
WO1996024603A1 (en) 1996-08-15
CA2212376A1 (en) 1996-08-15
US6033847A (en) 2000-03-07

Similar Documents

Publication Publication Date Title
AU4973896A (en) Ink4c-p18 and ink4d-p19, inhibitors of cyclin-depedent kinases cdk4 and cdk6, and uses thereof
AU1116497A (en) Inhibitors of cyclin-dependent kinases
AU8665998A (en) Irreversible bicyclic inhibitors of tyrosine kinases
ZA9810332B (en) Aminothiazone inhibitors of cyclin dependent kinases.
AU8760798A (en) Irreversible inhibitors of tyrosine kinases
AU4308397A (en) Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
AU5324996A (en) Protein kinase c inhibitors
AU4436396A (en) Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
AU7631496A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU1374797A (en) Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent
AU4915796A (en) Inhibitors of prenyl transferases
AU6157396A (en) Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors
AU2105001A (en) Systems and methods for providing consumers anonymous pre-approved offers from aconsumer-selected group of merchants
AU4920397A (en) Purine inhibitors of glycogen synthase kinase 3 (gsk3)
AU7289696A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
PL326754A1 (en) Inhibitors of proteinous kinase c
AU6691798A (en) Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
AU7370096A (en) Bis-heteroarylylmethoxyphenylketone derivatives as inhibitors of leukotriene biosynthesis
AU3094197A (en) Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
AU2208401A (en) Inhibitors of complement activation, their preparation and use
AU5599598A (en) Inhibitors of glycosyltransferases
AU6692996A (en) Inhibitors of apoptosis
AU7570996A (en) Quinoline derivatives as type iv phosphodiesterase inhibitors
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor